Read the Registration Document - Guerbet

3) Societal informationa) Territorial, economic and social impactAs an economic stakeholder in the regions where it operates, Guerbet is committed to modernising itsindustrial infrastructure and developing more ecological solutions. With this objective, €197 million wereinvested from 2005 to 2012 at the French sites of Aulnay (Seine-Saint-Denis), Lanester (Morbihan), Marans(Charente Maritime) and Gonesse (Val d’Oise). The employment generated from these activities is thuslargely local and regional.b) Relations with stakeholdersGuerbet supports different organisations and associations concerned by the development and activity of theGroup. Areas covered concern measures in favour of integration, general education and organisationshaving a connection with Guerbet's activities (for example, medical and pharmacy schools).The partnership with the association "Nos quartiers ont du talent" was in this way strengthened in 2012.This mentoring programme for young students from under-resourced urban districts engaged in a jobsearch enabled Guerbet employees to contribute their advice on CVs, letters of motivation or recruitmentinterviews.As for the Lanester site, it opened up its doors to young students from the Lorient University Institute ofTechnology (IUT) to provide them with an opportunity to discover the company, the different business linesand the requirements for a production site of active pharmaceutical ingredients.The Marans and Lanester sites, through local coordinating bodies (CLIC or Comité Local d’Information etde Concertation), engage with stakeholders that include residents from neighbouring areas, regionalgovernments and representatives of the central government, on the report evaluating their operatingactivity. In 2012, the status of the review of the PPRT technology risk prevention plans was presented.c) Subcontracting, suppliers and fair practicesThe Group's financial and purchasing policies establish in particular rules for ethical conduct in relationswith Guerbet's partners (suppliers, subcontractors, etc.). The Group is also subject to strict regulationsgoverning relations with professionals in the healthcare sector (for example, French DMOS act regulatingrelations between businesses and the medical profession).In 2012, Guerbet continued to participate in the CSR (Corporate Social Responsibility) committee of LEEM(1) . These exchanges provided an opportunity to share sector-based good practices and raise awareness ofinternal teams about the issue of "Responsible Purchasing".(1)"Les Entreprises du Médicament" – the French Pharmaceutical Companies Association69